Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. (KMTS) Revenue
Annual & quarterly revenue history · segment & region breakdown
KMTS · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsKestra Medical Technologies, Ltd. trailing twelve-month (TTM) revenue is $0.08B, an increase of 115.05% year-over-year from $0.06B in FY2025.
Revenue trend
2025 – 2020 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-04-30 | $0.06B | +$0.03B | +115.05% |
| 2024-04-30 | $0.03B | +$0.02B | +264.53% |
| 2023-04-30 | $0.01B | +$0.01B | — |
| 2021-04-30 | $0.00B | +$0.00B | — |
| 2020-04-30 | $0.00B | — | — |
Compare revenue vs peers
Medical - Instruments & SuppliesCompare KMTS revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Kestra Medical Technologies, Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Kestra Medical Technologies, Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Kestra Medical Technologies, Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
KMTS revenue · 4 questionsKMTS's trailing twelve-month (TTM) revenue is $0.08B. That is an increase of 115.05% year-over-year from $0.06B in FY2025.
▸ Source: FMP · Kestra Medical Technologies, Ltd. SEC filings · GAAP · Kestra Medical Technologies, Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026